Startup Spotlight: Extracting RNA to diagnose diseases on the cheap

first_img What is it? STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED About the Author Reprints What’s included? Biotech [email protected] By Meghana Keshavan Dec. 8, 2016 Reprints Log In | Learn More Biotech Correspondent Meghana covers biotech and contributes to The Readout newsletter.center_img Meghana Keshavan GET STARTED Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. Tags biotechnologyinfectious diseasemedical technologySTAT+Zika Virus @megkesh Modern bioscience has little reach in the more remote corners of our globe. A Detroit startup called Life Magnetics is looking to change that — by applying its next-gen RNA extraction method to build a new wave of inexpensive, point-of-care diagnostics for viral diseases like HIV, hepatitis C and Zika.The company has what amounts to a fancy tool to suck RNA out of cells. It’s a technique that’s already used in microfluidics, and in lab-on-a-chip technologies. But Life Magnetics is giving RNA extraction a bit of a makeover. I talked with CEO Kevin Hagedorn about the company, which is funded mostly through small grants from the National Science Foundation. Startup Spotlight: Extracting RNA to diagnose diseases on the cheap The new diagnostic tool would be used to identify viral diseases such as hepatitis C. APStocklast_img read more